Mammalian Drug Substance Manufacturing

Trust decades of successful drug development and manufacturing built on mammalian platforms

Emergent Mammalian Platform Technologies and Capabilities

Technologies Scale Downstream Processing


  • Monoclonal antibodies (mAbs)
  • Recombinant proteins 


  • 50L-4000L single-use-bioreactors 
  • 50L-200L stainless steel bioreactors
  • Closed aseptic processing systems
  • Centrifugation
  • Chromatography
  • Filtration
  • UF/DF

Let’s Start A Conversation

Connect now